Want to join the conversation?
Based on a strong bottom-line result, $XRAY increased its adjusted EPS guidance range for 2015 to be $2.58-2.64 as compared with the previous guidance of $2.54-2.62. Management expects the merger with Sirona Dental to be completed in the first quarter of 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?